Document:

Exhibit 4.64

 

NOTE PURCHASE AGREEMENT

 

THIS NOTE PURCHASE AGREEMENT
(the “Purchase Agreement”) is dated as of June 28, 2021, by and among Marpai, Inc., a Delaware corporation (the “Company”),
and those individuals and/or entities listed in Exhibit A attached hereto (each a “Lender” and together the
 “Lenders”).

 

WHEREAS, the Company desires
to raise up to Three Hundred Thousand Dollars ($300,000) (the aggregate “Loan Amount”) via a convertible note financing
from the Lenders and the Lenders wish to loan the Company the Loan Amount subject to the terms and conditions of this Purchase Agreement
and the convertible promissory note attached hereto as Exhibit B (each a “Note” and together the “Notes”);

 

NOW, THEREFORE, in consideration
of the premises and the mutual covenants herein contained, and other good and valuable consideration the receipt and sufficiency of which
is hereby acknowledged, the undersigned parties hereby agree as follows:

 

1.                  
Amount and Terms of the Notes. The Lenders undertake to lend to the Company the Loan Amount, in the proportions as set forth
opposite each Lender’s name in Exhibit A, against the issuance of the Notes. The Loan Amount shall bear a cumulative annual
interest as specified in the Note and shall have such maturity date set forth therein.

 

2.                  
Closing.

 

(a)               
Initial Closing. Subject to the terms and conditions of this Purchase Agreement, the initial closing of the sale and purchase of
the Notes hereunder shall take place remotely via the exchange of documents and signatures on such date and time as determined by the
Company (the “Initial Closing”). At the Initial Closing, the Company shall deliver a Note to each Lender participating
therein in the original principal amount set forth opposite each Lender’s name in Exhibit A and each Lender shall immediately
pay its respective portion of the Loan Amount as set forth opposite each Lender’s Name in Exhibit A by way of check or wire
transfer pursuant to the instructions provided by the Company to the Lenders prior to the Initial Closing.

 

(b)               
Additional Closings. Following the Initial Closing, at any time and from time to time during and up to and including December 31,
2021 (the “Additional Closing Period”), the Company may, at one or more additional closings as determined by the Company
(each an “Additional Closing” and together with the Initial Closing, a “Closing”), without obtaining
the signature, consent or permission of any of the Lenders in the Initial Closing or any prior Additional Closing, issue additional Notes
to other investors (the “New Lenders”) up to the portion of the Loan Amount remaining after the Initial Closing on
the same terms and conditions as set forth herein. The New Lenders may include persons or entities who are already Lenders under this
Purchase Agreement and each New Lender shall execute and deliver a signature page to this Purchase Agreement and the Note to the Company,
becoming a party to, and bound by, this Agreement to the same extent as if the New Lender had been a Lender at the Initial Closing and
each such New Lender shall be deemed to be a Lender for purposes under this Agreement as of the date of the applicable Additional Closing.
The Company, in its sole discretion, may shorten the Additional Closing Period.

 

3.                  
Representations and Warranties of the Company. The Company represents and warrants to the Lenders as follows:

 

(a)               
The Company is duly organized and existing in good standing under the laws of State of Delaware, and has the power to own its properties
and to carry on its business as now conducted.

 

     

     

    

 

(b)               
The Company has full power, authority and legal right to enter into this Purchase Agreement and each Note and to perform all of its
obligations thereunder. The Company has duly executed and delivered this Purchase Agreement and each Note. This Purchase Agreement
and the Note constitute the legal, valid, and binding obligation of the Company enforceable in accordance with their respective
terms.

 

(c)               
All of the shares of the Company to be issued to the Lender upon the conversion of each Note (if converted) shall be, when issued, duly
authorized, validly issued, fully paid, non-assessable free and clear of all liens, pledges, security interests, charges and encumbrances
and registered in the name of the Lender on the stock ledger of the Company.

 

4.                  
Representations and Warranties of the Lender. Each Lender represents and warrants to the Company that:

 

(a)               
The Lender has sufficient knowledge and experience in investing in companies similar to the Company in terms of the Company’s stage
of development so as to be able to evaluate the risks and merits of its investment in the Company and it is able financially to bear the
risks thereof;

 

(b)               
The Lender is entering into this Purchase Agreement and acquiring the Note for the Lender’s own account for the purpose of investment
and not with a view to or for sale in connection with any distribution thereof other than in compliance with the Securities Act of 1933,
as amended (the Securities Act”) and applicable state securities laws;

 

(c)               
No “Bad Actor” Disqualification Events. Neither the Lender nor any of its directors, executive officers, other officers
that may serve as a director or officer of any company in which it invests, general partners or managing members is subject to any “Disqualification
Event” (as described in Rule 506(d)(1)(i)-(viii) of the Securities Act), except a Disqualification Event as to which Rule 506(d)(2)(ii–iv)
or (d)(3), is applicable); and

 

(d)               
Each Lender understands that (i) each Note and the securities into which it is convertible have not been registered under the Securities
Act by reason of its issuance in a transaction exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2)
thereof or Rule 504, 505 or 506 promulgated under the Securities Act, (ii) each Note and its underlying securities must be held indefinitely
unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such registration, and (iii) each Note
and its underlying securities will bear a legend substantially to such effect.

 

(e)               
 “Market Stand-off” Agreement. Each Lender hereby agrees that it will not, without the prior written consent of
the managing underwriter, during the period commencing on the date of the final prospectus relating to the registration by the
Company for its own behalf of its common stock or any other equity securities under the Securities Act on a registration statement
on Form S-1 or Form S-3, and ending on the date specified by the Company and the managing underwriter (such period not to exceed one
hundred eighty (180) days in the case of the IPO, or ninety (90) days in the case of any registration other than the IPO, or such
other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (1) the publication or
other distribution of research reports and (2) analyst recommendations and opinions, including, but not limited to, the restrictions
contained in FINRA Rule 2241, or any successor provisions or amendments thereto), (i) lend; offer; pledge; sell; contract to sell;
sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase;
or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or
exercisable or exchangeable (directly or indirectly) for common stock (whether such shares or any such securities are then owned by
the Lender or are thereafter acquired) or (ii) enter into any swap or other arrangement that transfers to another, in whole or in
part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii)
above is to be settled by delivery of common stock or other securities, in cash, or otherwise. The foregoing provisions of this Subsection
3(l) shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, or the transfer of any
shares to any trust for the direct or indirect benefit of the Lender or the immediate family of the Lender, provided that the
trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided further that any such
transfer shall not involve a disposition for value, and shall be applicable to the Lenders only if all officers and directors and
stockholders individually owning more than one percent (1%) of the Company’s outstanding common stock are subject to the same
restrictions. The underwriters in connection with such registration are intended third-party beneficiaries of this Subsection
3(l) and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. Each
Lender further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such
registration that are consistent with this Subsection 3(l) or that are necessary to give further effect thereto. Any
discretionary waiver or termination of the restrictions of any or all such agreements by the Company or the underwriters shall apply
pro rata to all Company stockholders that are subject to such agreements, based on the number of shares subject to such agreements. 

 

     

     

    

 

5.                  
Conversion. The Notes shall be convertible pursuant to the terms contained therein.

 

6.                  
Miscellaneous.

 

6.1              
Entire Agreement. This Purchase Agreement constitutes the entire understanding of the parties hereto with respect to the
subject matter hereof and supersedes all prior written and oral understandings of such parties with regard thereto. This Purchase Agreement
and the attached Note may be modified, amended, or any term hereof waived with the written consent of the Company and Lenders holding
a majority in interest of the Loan Amount. Any amendment effected in accordance with this Section 6.1 shall be binding upon all parties
of this Purchase Agreement and their respective successors and assignees.

 

6.2              
Governing Law; Jurisdiction. This Purchase Agreement shall be governed by and construed according to the laws of the State
of New York without regard to the conflict of laws provisions thereof. Any dispute arising under or in relation to this Purchase Agreement
shall be resolved in the competent courts of the State of New York, and each of the parties hereby submits irrevocably to the jurisdiction
of such court.

 

6.3              
Notices. All notices or other communications hereunder shall be in writing and shall be given in person, by registered mail
(registered air mail if mailed internationally), by an overnight courier service which obtains a receipt to evidence delivery, or by facsimile
transmission (provided that written confirmation of receipt is provided), addressed as set forth below:

 

	If to the Company:	Marpai,
    Inc.
	 	5701
    East Hillsborough Ave.
	 	Tampa,
    FL 33610
	 	Attn:
    Edmundo Gonzalez, Secretary
	 	 
	 	With
    a copy to:
	 	Pearl
    Cohen Zedek Latzer LLP
	 	131
    Dartmouth Street, Floor 3
	 	Boston,
    MA 02116
	 	Fax: (617)
    228-5720
	 	Attn:
    Oded Kadosh, Esq.
	 	 
	If to the Lender:	to
    the address as set forth in Exhibit A

 

     

     

    

 

or such other address as any
party may designate to the other in accordance with the aforesaid procedure. All notices and other communications delivered in person
or by courier service shall be deemed to have been given as of one business day after sending thereof, those given by facsimile transmission
with confirmed answer back (provided that such date is a business day in the country of receipt and if not, the next business day) and
all notices and other communications sent by registered mail shall be deemed given ten (10) days after posting.

 

6.4              
Assignment. This Purchase Agreement may not be assigned by any Lender without the prior written consent of the Company.
The Company may assign this Purchase Agreement without the prior written consent of the Lenders. Notwithstanding the foregoing, this Purchase
Agreement shall be binding upon the successors, assigns and representatives of each party.

 

6.5              
No Waiver. No delay or omission to exercise any right, power, or remedy accruing to any party upon any breach or default
under this Purchase Agreement, shall be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies,
either under this Purchase Agreement or by law or otherwise afforded to any of the parties, shall be cumulative and not alternative.

 

6.6              
Severability. If any provision of this Purchase Agreement is held by a court of competent jurisdiction to be unenforceable
under applicable law, then such provision shall be excluded from this Purchase Agreement and the remainder of this Purchase Agreement
shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms; provided, however, that
in such event this Purchase Agreement shall be interpreted so as to give effect, to the greatest extent consistent with and permitted
by applicable law, to the meaning and intention of the excluded provision as determined by such court of competent jurisdiction.

 

6.7              
Counterparts. This Purchase Agreement may be executed in any number of counterparts, each of which shall be deemed an original
but all of which together shall constitute one and the same instrument.

 

6.8              
Further Assurances. Each of the parties hereto shall perform such further acts and execute such further documents as may
reasonably be necessary to carry out and give full effect to the provisions of this Purchase Agreement and the intentions of the parties
as reflected thereby.

 

6.9              
Headings. All article and section headings herein are inserted for convenience only and shall not modify or affect the construction
or interpretation of any provision of this Purchase Agreement.

 

6.10          
Expenses. Each Lender will bear its own fees and expenses incurred in the transactions contemplated herein.

 

[signatures to follow]

 

     

     

    

 

IN WITNESS WHEREOF, the parties
have executed this Note Purchase Agreement as of the date first above written.

 

	THE
    COMPANY:	 
	 	 
	MARPAI,
    INC.	 
	 	 
	By:	/s/
    Yaron Eitan	 
	Name:	Yaron
    Eitan	 
	Title:	Chairman	 

 

[Company signature page to the Purchase Agreement
of Marpai, Inc.]

  

     

     

    

 

IN WITNESS WHEREOF, the parties
have executed this Note Purchase Agreement as of the date first above written.

 

	THE
    LENDER:	 
	 	 
	Grays
    West Ventures LLC	 
	 	 
	By:	/s/
    Edmundo Gonzalez	 
	Name:	Edmundo
    Gonzalez	 
	Title:	Manager	 

 

[Lender signature page to the Purchase Agreement
of Marpai, Inc.]

 

     

     

    

 

Exhibit A

 

Final Lenders Schedule (As of June 11, 2021)

 

	Name	 	Address	 	 	Loan Amount	 
	Jane Cavalier Lucas	 	 	 	 	 	$	75,000.00	 
	Steve Johnson	 	 	 	 	 	$	50,000.00	 
	Wayne Watters	 	 	 	 	 	$	50,000.00	 
	Phil Blank	 	 	 	 	 	$	50,000.00	 
	Susan Cain	 	 	 	 	 	$	30,000.00	 
	Grays West Ventures LLC	 	 	 	 	 	$	45,000.00	 
	TOTAL:	 	 	 	 	 	$	300,000.00	 

  

     

     

    

 

Exhibit B

 

THIS NOTE AND THE SECURITIES
ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED, INCLUDING UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED
FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT, AND (2) SUBJECT TO
THE PROVISIONS OF ANY OTHER APPLICABLE LAW AND OF THE THEN CURRENT BY-LAWS AND CERTIFICATE OF INCORPORATION OF THE COMPANY.

  

CONVERTIBLE PROMISSORY NOTE

 

	$45,000.00 (the “Loan Amount”)	June 28, 2021
	8% Annual Interest	(the “Note Date”)

 

THIS NOTE is issued pursuant
to the terms of that certain Note Purchase Agreement by and among Marpai, Inc. (the “Company”), GRAYS WEST VENTURES
LLC (the “Lender”) and dated June 28, 2021 (the “Purchase Agreement”). Capitalized terms
not elsewhere defined herein shall have the meanings set forth in the Purchase Agreement.

 

FOR VALUE RECEIVED, the Company
hereby promises to pay to the order of the Lender, the principal sum of the Loan Amount, together with interest thereon. This Note shall
bear a simple interest rate of eight percent (8%) per annum based on a 365 day year. The obligation to pay interest on this Note shall
be cumulative.

 

1.                  
Maturity Date. If not otherwise converted pursuant to Section 3, the outstanding principal balance and unpaid accrued interest
on this Note shall be due two (2) years from the Note Date (the “Maturity Date”) or prior thereto upon the Lender’s
first written request following an Event of Default of the Company. The Maturity Date may be extended upon mutual consent of the Company
and the Lender.

 

2.                  
Note Repayment. All repayments shall be made in lawful money of the United States of America by wire transfer to a bank
account to be designated by the Lender. All Notes outstanding under the Purchase Agreement, and any other Note Purchase Agreement outstanding
by the Company as of the date hereof, shall rank equally without preference or priority of any kind with respect to one another, and all
payments with respect to any of the Notes that have not been converted shall be applied ratably in proportion to the Loan Amounts represented
thereby. The Company shall be entitled to repay all or any portion of the principal or accrued interest outstanding under the Notes upon
prior written notice to the Lender.

 

3.                  
Conversion.

 

3.1               Automatic
Conversion upon Initial Public Offering. If, after the date hereof and prior to the
earlier of the Maturity Date or the full repayment or conversion of the Notes, the Company (or a successor entity) closes an
underwritten public offering of its common stock (an “IPO”), then the entire principal amount of this Note and
accrued interest (calculated through the date that is ten (10) days prior to the closing of the IPO) will be converted
automatically, without the need for any action on the part of Company or the Lender, into unregistered shares of common stock of the
Company (or successor entity, as applicable) concurrently with the closing of the IPO. The number of shares of common stock issuable
upon conversion of this Note will be calculated by dividing the total of the principal amount of and accrued interest on this Note
(calculated through the date set forth above in this Section 3.1) then outstanding by 70% of the per share public offering
price stated on the front cover of the final prospectus for the IPO (before deduction of any underwriting commissions, expenses or
other amounts). The Company will give the Lender notice of the intended closing of an IPO, including the public offering price,
provided that the failure to give such notice will not affect the automatic conversion of this Note. In order to receive
certificates representing the common stock, the Lender must cause the original of this Note to be delivered to the Company, or if
lost, stolen or destroyed, an affidavit and, if reasonably requested by the Company, a reasonable indemnity as to the lost, stolen
or destroyed original of this Note. Then, the Company (or successor entity) will cause one or more stock certificates evidencing the
Lender’s ownership of the number of conversion shares into which the principal amount of, and interest accrued on, this Note
has been converted to be delivered promptly to the Lender or as directed by the Lender. From and after the IPO, this Note will
represent only the right to receive shares of common stock (or shares of a successor entity’s common stock).

 

     

     

    

 

3.2              
Automatic Conversion upon Qualified Financing. Notwithstanding the foregoing, at the closing of the Qualified Financing
(as hereinafter defined), the outstanding principal balance and unpaid accrued interest on this Note shall be automatically converted
into the most senior class of shares of the Company issued in such Qualified Financing (the “Shares”) at a price per
share equal to a 30% discount from the company valuation at the applicable round of financing (the “Conversion Price”).
The exact number of Shares to be issued to Lender upon conversion will be equal to the aggregate outstanding principal and unpaid accrued
interest due on this Note, divided by the Conversion Price. The issuance of such shares upon conversion of this Note shall be contingent
upon execution and delivery by the Lender of the agreements executed and delivered by investors in the Qualified Financing. The Lender
shall thereupon receive all of the rights, preferences and privileges granted to other investors in the Qualified Financing, including
but not limited to any registration and piggyback rights. “Qualified Financing” shall mean the next transaction or
series of related transactions, other than an IPO, following the date of the Purchase Agreement in which the Company issues and sells
Shares to investors, which may be existing stockholders of the Company, with gross proceeds to the Company of at least two million dollars
(US$2,000,000), excluding the conversion of Notes.

 

3.3              
Discretionary Conversion. Unless otherwise automatically converted upon an IPO or in a Qualified Financing, at any time
after the Maturity Date (or any time after the Maturity Date with the consent of the Company and including prior to a Change of Control
that occurs before a Qualified Financing or IPO) the Lender shall be entitled, by written notice to the Company, to convert the outstanding
principal balance and unpaid accrued interest on this Note, in whole or in part, into the most senior class of stock of the Company then
outstanding, at a conversion price based upon a maximum company pre-money valuation of Forty-Eight Million Two Hundred Sixty-Two Thousand
Dollars (US$48,262,000) on a fully diluted basis. The shares issued upon said conversion shall have all preferential and associated rights
with said class and given to the investors in the applicable round of financing, and shall be identical in all terms except for said price.
Any election to convert the Note pursuant to this Section 3.3 will be made in writing and delivered to the Company.

 

     

     

    

 

3.4               Repayment
Upon Change of Control. In the event the Company consummates a Change of Control (as defined below) prior to the Maturity Date
and prior to the conversion or repayment of this Note, then this Note shall become due and payable upon the date of consummation of
such Change of Control (and following the Company’s receipt of proceeds from a Change of Control) in an amount equal to the
greater of: (i) one and one half times (1.5x) the Loan Amount, plus any accrued and unpaid interest; or (ii) the net proceeds to be
received by Lender if Lender had converted this Note based on a price per share based on a pre-money valuation of the Company equal
to $35,000,000, as calculated on a fully diluted basis, immediately prior to the Change of Control. The Company will notify Lender
in writing of a Change of Control at least five (5) days before the anticipated closing of such Change of Control. A
 “Change of Control” means the sale, conveyance, exclusive license outside of the ordinary course of business, or
other disposition of all or substantially all of the Company’s property or business, the Company’s merger with or into
or consolidation with any other corporation, limited liability company or other entity (other than a wholly owned subsidiary of the
Company) if the holders of the voting securities of the Company that are outstanding immediately prior to the consummation of such
consolidation or merger do not, immediately after the consummation of such consolidation or merger, hold voting securities that
collectively possess at least a majority of the voting power of all the outstanding securities of the surviving entity of such
consolidation or merger or such surviving entity’s parent entity or the sale or disposition of a majority of the voting
securities of the Company; provided that the term “Change of Control” shall not include (a) a merger or reorganization
of the Company effected exclusively for the purpose of changing the domicile of the Company or tax-free reorganization or (b) an
equity financing in which the Company is the surviving corporation.

 

4.                  
Unsecured Obligation. The Lender hereby acknowledges and agrees that the obligations of the Company hereunder (including,
without limitation, in respect of repayment of the Loan Amount and the accrued but unpaid interest thereon) shall be an unsecured obligation
of the Company in all respects.

 

5.                  
Governing Law; Venue. This Note and all acts and transactions pursuant hereto and the rights and obligations of the parties
hereto shall be governed, construed and interpreted in accordance with the laws of the State of New York without regard to the conflict
of law provisions. The competent courts of the State of New York shall have exclusive jurisdiction to resolve all disputes arising from
or in connection with this Note or the Purchase Agreement.

 

6.                  
Transfer; Successors and Assigns. The Lender may not sell, assign, pledge, dispose of or otherwise transfer (collectively,
 “Transfer”) this Note, unless the Lender obtains the Company’s prior written approval (such approval to be provided
in the Company’s sole and absolute discretion).

 

7.                  
Notices. The notice provision of the Purchase Agreement shall apply to this Note.

 

8.                  
Amendments, Modifications. Any amendment or modification of this Note shall require the prior written consent of the Company
and the Lender.

 

9.                  
Miscellaneous. The Company hereby expressly waives presentment, demand for payment, dishonor, notice of dishonor, protest,
notice of protest and any other formality.

 

10.                
Stock Reclassifications; Stock Splits, Combinations and Dividends. If the Shares issuable upon the conversion of this Note
shall be changed into the same or different number of Shares of any class or classes of stock, whether by reclassification, stock split,
stock dividend, or similar event, then and in each such event, the Lender, shall have the right thereafter to convert all or any portion
of this Note into the kind and amount of Shares and property receivable upon such capital reorganization, reclassification or other change
which the Lender would have received had this Note been converted immediately prior to such capital reorganization, reclassification or
other change.

 

11.                Adjustments.
The Company will make an appropriate adjustment to the number of Shares issuable upon conversion and/or the Conversion Price thereof
upon any stock split, combination, dividend, distribution, recapitalization, reorganization, or similar event affecting the
Company’s capital stock other than cash dividends paid or payable from retained earnings (collectively, a "Stock
Event"), so that the Lender will receive, upon conversion, all Shares, dividends, rights and benefits to which the Lender
would have been entitled had Lender converted this Note prior to such Stock Event. The form of this Note need not be changed by
reason of any such adjustment. Any successor entity to the Company will execute and deliver to the Lender a supplement hereto
acknowledging such entity's obligations under this Note. The Company will make adjustments as soon as practicable following any
Stock Event, and immediately thereafter give notice to the Lender of all facts and calculations associated with such adjustment.
Stock Event adjustments may be waived by the Lender, in its sole and absolute discretion.

 

     

     

    

 

12.                
Default. If there shall be any Event of Default (as defined below) hereunder, at the option and upon the declaration of
the Lender of this Note and upon written notice to the Company (which election and notice shall not be required in the case of an Event
of Default under Section 12(b) or 12(c)), this Note shall accelerate and all Loan Amount and unpaid accrued interest shall become due,
payable and collectible. The occurrence of any one or more of the following shall constitute an “Event of Default”
hereunder:

 

(a)            
The Company fails to pay timely any of the Loan Amount due under this Note on the date the same becomes due and payable or any
accrued interest or other amounts due under this Note on the date the same becomes due and payable or within five (5) business days thereafter;

 

(b)            
The Company files any petition or action for relief under any bankruptcy, reorganization, insolvency or moratorium law or any other
law for the relief of, or relating to, debtors, now or hereafter in effect, or makes any assignment for the benefit of creditors or takes
any corporate action in furtherance of any of the foregoing; or

 

(c)            
An involuntary petition is filed against the Company (unless such petition is dismissed or discharged within sixty (60) days) under
any bankruptcy statute now or hereafter in effect, or a custodian, receiver, trustee, assignee for the benefit of creditors (or other
similar official) is appointed to take possession, custody or control of any property of the Company and is not removed within sixty (60)
days from the date of such appointment.

 

(d)            
If the Company shall admit in writing to its inability to pay its debts as they mature and Lender has elected to not convert this
Note.

 

(e)            
If a judgment creditor shall file or commence any levy of attachment, execution or other similar process against the assets of
the Company valued in excess of $100,000 which potential loss is not covered by insurance or which proceeding is not being contested in
good faith by the Company, provided however, that such event shall not be an Event of Default if the Company cures such event within sixty
(60) days after receiving notice of the Event of Default contemplated under this subsection.

 

(f)             
If the Company commits fraud at any time in connection with this Note.

 

 13.                 Default Remedies.

 

(a)               If an Event of
Default (other than an insolvency Event of Default) has occurred and is continuing, the Lender, by notice to the Company, may declare
the Loan Amount of this Note and all accrued interest thereon to be immediately due and payable, and upon any such declaration, such Loan
Amount and accrued interest shall thereupon become due and payable immediately within five (5) business days from the Lender’s written
request. In the event the Company fails to pay all outstanding Amounts within this five (5) business day period, the interest rate on
the unpaid and outstanding Loan Amount of this Note shall be increased to, and this Note shall bear interest at, a monthly rate equal
to one and a half percent (1.5%) or to the maximum rate permitted by law (the "Default Rate") from the expiration of
the five (5) business day period until such unpaid and outstanding Loan Amount of this Note is repaid in full. If an insolvency Event
of Default has occurred, the Loan Amount of this Note and accrued Interest thereon will become immediately due and payable without any
declaration or any act on the part of any Lender. Such declaration of acceleration may be rescinded and past defaults may be waived by
the Lender.

 

     

     

    

 

(b)              No
course of dealing or delay or failure on the part of the Lender to exercise any right under this Section shall operate as a waiver
of such right or otherwise prejudice the Lender’s rights, powers and remedies. The Company will pay or reimburse the Lender,
to the extent permitted by law, for all reasonable costs and expenses, including but not limited to reasonable attorneys’
fees, incurred by the Lender in collecting any sums due on this Note or in otherwise enforcing any of the Lender's rights
hereunder.

 

(c)             No right or remedy
herein conferred upon the Lender is intended to be exclusive of any other right or remedy contained herein or existing at law, in equity,
by statute or otherwise, and every such right or remedy shall be cumulative and shall be in addition to every other such right or remedy
contained herein and therein or now or hereafter existing at law, in equity, by statute or otherwise.

 

14.       Indemnity.
The Company agrees to indemnify and hold the Lender harmless from and against any and all suits, actions, proceedings, claims, damages,
losses, liabilities and expenses of any kind and nature whatsoever (including attorneys' fees and disbursements and other costs of investigation
or defense) that may be instituted or asserted against or incurred by the Lender as the result of credit having been extended, suspended
or terminated under this Note or with respect to the execution, delivery, enforcement, performance and administration of, or in any other
way arising out of or relating to, this Note or the transactions referred to herein and any actions or omissions with respect to any of
the foregoing, except to the extent that the Lender is finally determined by a court of competent jurisdiction to have resulted solely
from the gross negligence or willful misconduct of the Lender.

 

15.        Replacement
of Note. If the Lender of record loses this Note, the Company shall issue an identical replacement Note to the Lender upon the Lender’s
delivery to the Company of an executed lost note affidavit stating the facts surrounding such loss of this Note and an executed indemnity
agreement indemnifying and holding harmless the Company against any losses incurred or liabilities suffered by the Company or claims against
the Company by any other holders or transferees of this Note related to or from the issuance of the replacement Note by the Company, which
lost note affidavit and indemnity agreement shall be in a form reasonably satisfactory to the Company.

 

16.       Reinstatement.
This Note shall continue to be effective, or be reinstated, as applicable, if at any time payment of all or any part hereof is rescinded
or must otherwise be returned or restored by the Lender upon the insolvency, bankruptcy, dissolution, liquidation or reorganization of
the Company, as though such payments had not been made.

 

17.       Additional
Covenants. Until this Note is paid in full, the Company shall not without the prior written consent of the Lenders holding a majority
in interest of the Loan Amount. (such consent which shall not be unreasonably delayed, withheld, or conditioned): (i) issue any securities
other than strictly pursuant to a Qualified Financing, IPO or pursuant to a duly adopted Stock Incentive Plan; (ii) incur or agree to
incur any indebtedness that is senior to this Note (except for the SQN Note as hereinafter defined) ; (iii) make any loans to, or assume
or guarantee any debt or other obligations of another person or entity in excess of $10,000; (iv) enter into or modify any affiliated
party transaction or pay current officers and directors in excess of that which has previously been disclosed in writing to the Lender;
(v) place any liens or encumbrances on, or cause any liens or encumbrances to be placed on, or transfer, convey, assign, pledge or grant
any security interests in, the capital stock or assets or properties of the Company other than those liens that may be granted to SQN
under the SQN Note; or (vi) declare or pay any dividends or distributions on its capital stock until this Note is paid in full.

 

     

     

    

 

18.       Financial
Statements. So long as this Note is outstanding, the Company shall furnish to the Lender:

 

(a)       Monthly
Reports. Within thirty (30) days following the end of each fiscal month of the Company, a copy of the consolidated and consolidating
balance sheet, income statement and statement of cash flow (the "Financial Statements") of the Company and its subsidiaries,
internally prepared for such fiscal month in accordance with generally accepted accounting principles in the United States, consistently
applied, setting forth in comparative form the corresponding figures for that date and period, accompanied by a certificate executed by
the Chief Executive Officer or Chief Financial Offer of the Company certifying that (i) such Financial Statements are complete, true and
correct and (ii) to his or her actual knowledge, the Company is not in default of any of its covenants made hereunder.

 

(b)       Annual Reports.
Within ninety (90) days following the close of each fiscal year of the Company, the Financial Statements for such fiscal year certified
by an officer of the Company without qualification in reasonable detail, setting forth in comparative form the corresponding figures for
the corresponding date and period in the preceding fiscal year, and accompanied by other detailed reports from such accountants to the
Company (including, without limitation, any management letters) in connection with each annual or interim audit or review of the books
of the Company by such accountants. In the event the Board of Directors of the Company approves the annual Financial Statements to be
audited, the Lender shall be provided with Financial Statements audited by an independent certified public accounting firm reasonably
acceptable to the Lender.

 

19.        Seniority.
The Lender hereby confirms and acknowledges that this Note shall rank pari passu in seniority with any other Note issued under the Purchase
Agreement or any other Note Purchase Agreements outstanding by the Company as of the date hereof, including those notes issued under that
certain note purchase agreement entered into in May, 2020, by and between the Company and the lenders indicated therein. The Lender further
confirms and acknowledges that this Note shall rank junior in all respects (including in respect of payment) to that certain promissory
note that may be issued by the Company to SQN Venture Income Fund, L.P., or an affiliate thereof (“SQN”) in the aggregate
amount of up to $3,000,000 (the “SQN Note”) in respect of the Company purchasing certain assets of SQN (the “SQN
Transaction”). Nothing herein shall obligate the Company to consummate the SQN Transaction or issue the SQN Note but in the
event the SQN Transaction is consummated, and the SQN Note is issued by the Company in connection therewith, the SQN Note, and any lien
granted to SQN thereunder, shall be deemed senior and first ranking in all respects to this Note. The Lender hereby consents to the SQN
Transaction and the senior SQN Note and undertakes to execute any document, or take any action, reasonably requested by the Company or
SQN to subordinate this Note to the SQN Note.

 

[Remainder of Page Intentionally
Left Blank]

 

     

     

    

 

IN WITNESS WHEREOF, the Company
has executed this Note as of the date first above written.

 

	 	THE COMPANY:
	 	 
	 	MARPAI, INC.
	 	 
	 	By:	 /s/ Yaron Eitan
	 	Name: 	Yaron Eitan
	 	Title:	 Chairman

  

	Approved and Agreed:	 
	 	 
	THE LENDER:	 
	 	 
	GRAYS WEST VENTURES LLC	 
	  	 
	By:	 /s/ Edmundo Gonzalez	 
	Name:	Edmundo Gonzalez	 
	Title:	Manager	 

 

[SIGNATURE PAGE TO CONVERTIBLE PROMISSORY NOTE]Exhibit 4.65

 

AGREEMENT RELATING TO VOTING
POWER BETWEEN CO-FOUNDERS OF MARPAI, INC. AND

GRANT OF A POWER OF ATTORNEY
AND PROXY

 

This agreement
relating to the vote of shares of Marpai, Inc., a Delaware corporation (“Marpai Stock” and “Marpai”,
respectively) and the grant of a power of attorney and proxy (this “Agreement” and the “Power of Attorney and Proxy”,
respectively) is entered into by and between, Hillcour Investment Fund LLC, WellEnterprises USA LLC, Eli David, Yaron Eitan, Edmundo Gonzalez
and Grays West Ventures LLC (wholly owned by Edmundo Gonzalez), the co-founders of Marpai (each a “Co-Founder”, and
collectively the “Co-Founders”), and is effective as of June 28, 2021 (the “Effective Date”).

 

1.             As
of the Effective Date, HillCour Investment Fund LLC and WellEnterprises USA LLC (together the “Hillcour Founding Group”)
collectively hold 1,201,431 issued and outstanding shares of Class A common stock of Marpai, $0.0001 par value each (“Class
A Marpai Stock” and the Class A Marpai Stock as owned by the Hillcour Founding Group, the “Hillcour Shares”),
and Eli David, Yaron Eitan, Edmundo Gonzalez and Grays West Ventures LLC (together the “Grays Founding Group”) collectively
hold 516,488 issued and outstanding shares of Class A Marpai Stock (“Grays Shares”).

 

2.             Subject
to the terms hereof, the Co-Founders agree to maintain the voting power of the Hillcour Founding Group, on the one hand, to be as equal
as possible to the voting power of the Grays Founding Group, on the other hand at all times (the “Equal Votes Principle”).
The Co-Founders agree and acknowledge that this Agreement will benefit Marpai and its stockholders.

 

3.             The
Hillcour Founding Group hereby grants a Power of Attorney and Proxy, in substantially the form attached hereto as Exhibit A, to the Grays
Founding Group to vote 342,471 Hillcour Shares (the “Proxy Shares”), so that the Hillcour Founding Group and the Grays
Founding Group shall have the right to vote 858,960 shares of Class A Marpai Stock and 858,959 shares of Class A Marpai Stock, respectively,
subject to adjustment as set forth herein. For avoidance of doubt, the Power of Attorney and Proxy is an integral part of this Agreement
and is incorporated into this Agreement for all purposes.

 

4.             The
number of Proxy Shares shall be adjusted so that the Equal Votes Principle is maintained, if a Co- Founder:

 

		(i)	exercises any options or warrants to purchase Marpai Stock,

		(ii)	is issued additional Marpai Stock upon conversion of any notes or other instruments
convertible into Marpai Stock, which notes or instruments are outstanding as of the Effective Date,

		(iii)	receives any shares of Marpai Stock as equity incentive compensation (as a director,
officer or employee of Marpai), or

		(iv)	sells or transfers any of such Co-Founder’s shares of Marpai Stock to a third-party
which is not an Affiliate of (a) any person or entity within the Grays Founding Group, (b) any person or entity within the Hillcour Founding
Group or (c) Damien Francis Lamendola.

 

 5.             The term "Affiliate" shall mean any entity, individual, firm, or corporation, directly or indirectly, through one or more intermediaries, controlling, controlled by, or under common control with a party to this Agreement.

 

6.              Notwithstanding
anything to the contrary, any adjustment will be accomplished in a manner which maintains the Equal Votes Principle between the Hillcour
Founding Group and Grays Founding Group. All Co- Founders undertake to vote their shares and/or sign any instrument to give effect to
such adjustments.

 

[Signature Page to Follow]

 

     

     

    

 

IN WITNESS WHEREOF, the undersigned executed this Agreement
as of this 28th day of June 2021.

 

 

	 	HILLCOUR INVESTMENT FUND LLC
	 	 
	 	By:  /s/ Damien Lamendola                             
	 	 
	 	Name:  Damien Lamendola                              
	 	 
	 	Title:  Manager                                                  
	 	 
	 	 
	 	 
	 	WELLENTERPRISES USA LLC
	 	 
	 	By:  /s/ Philip G.
    Mowry                                  
	 	 
	 	Name:  Philip G. Mowry                                   
	 	 
	 	Title:  Manager                                                  
	 	 
	 	 
	 	 
	 	ELI DAVID
	 	 
	 	By:  /s/ Eli David                                               
	 	 
	 	 
	 	 
	 	YARON EITAN
	 	 
	 	By:  /s/ Yaron Eitan                                          
	 	 
	 	 
	 	 
	 	EDMUNDO GONZALEZ
	 	 
	 	By:  /s/ Edmundo Gonzalez                             
	 	 
	 	 
	 	 
	 	GRAYS WEST VENTURES LLC
	 	 
	 	By:  /s/ Edmundo Gonzalez                             
	 	 
	 	Name:  Edmundo Gonzalez                              
	 	 
	 	Title:  Manager                                                  

 

     

     

    

 

Exhibit A

 

POWER OF ATTORNEY AND PROXY

 

This Power of Attorney and Proxy is
an integral part of the Agreement to which it is attached. Capitalized terms used but not otherwise defined herein shall have the meanings
assigned to them in the Agreement.

 

1.            The
undersigned, Hillcour Founding Group (the “Empowering Holders”), hereby constitutes and appoints Grays Founding Group
(the “Attorney-in-Fact”) as its true and lawful agent, attorney-in-fact and proxy with full power and authority to
vote the Proxy Shares, at a meeting or sign on actions by written consents in connection with any of the following actions:

		(i)	Any change to the composition of the Board of Directors of Marpai; provided that
all Proxy Shares shall be voted for the election of Damien Francis Lamendola (or another nominee of the Hillcour Founding Group) as a
director of Marpai (as well as against any proposal to remove Damien Francis Lamendola (or such other nominee) as a director of Marpai).

		(ii)	The sale of all or substantially all of the assets of Marpai, the sale of all or
substantially all of the capital stock of Marpai, or a merger involving Marpai.

		(iii)	Replacement of the CEO or other C-level officers of Marpai.

		(iv)	Amending the corporate documents of Marpai or otherwise approve any agreement, document
or instrument in connection with fundraising of any type or structure for Marpai.

		(v)	Approval of annual budget and business plan of Marpai; and

		(vi)	Acquire any business or entity or otherwise enter into a joint venture or other
collaborative agreement with a potential target business, assets, entity, or partner.

 

2.             The
Attorney-in-Fact is authorized and empowered to take all actions and to do all things necessary or proper, required, contemplated or
deemed advisable by the Attorney-in-Fact in its discretion to vote the Proxy Shares on such actions in a manner consistent with the foregoing,
including the execution and delivery of all documents (including but not limited to the execution of written consents of the stockholders
and voting as a stockholder in Marpai), and generally to act for and in the name of Empowering Holders to vote the Proxy Shares as fully
as would the Empowering Holders then personally present and acting.

 

 3.             This Power of Attorney and Proxy is irrevocable, and it shall remain in full force and effect, with respect to the Proxy Shares, as adjusted (if any), until the earlier of the consummation of the sale of all or substantially all of the assets of Marpai, or the acquisition of Marpai by a third party (by a way of a stock acquisition, merger, recapitalization or otherwise) or the time when the Grays Founding Group owns collectively less than 413,190 issued and outstanding shares of Marpai Stock (a “Termination Event”).

 

4.             Until
the Termination Event, and unless otherwise agreed to in writing unanimously by the Co-Founders, the Attorney-in-Fact and the Co-Founders
will not take any action, or sign any document, in connection with the Power of Attorney and Proxy granted hereunder which may be inconsistent
with the Agreement.

 

5.             
Notwithstanding anything else set forth in this Power of Attorney and Proxy, the Hillcour Founding Group shall have the right to
sell the Proxy Shares and any other Marpai Stock that it owns at any time; provided that, if a purchaser of the Proxy Shares or any other
Marpai Stock that the Hillcour Founding Group owns is an Affiliate of any person or entity within the Hillcour Founding Group or an Affiliate
of Damien Francis Lamendola, the Hillcour Founding Group shall cause such purchaser to be bound by this Power of Attorney and Proxy.

 

6.              Unless otherwise agreed to in writing unanimously by the Co-Founders, the Co-Founders shall vote their Marpai Stock for the election
of (i) Damien Francis Lamendola (or another nominee of the Hillcour Founding Group), (ii) Edmundo Gonzalez and (iii) Yaron Eitan (or up
to two other nominees of the Grays Founding Group) as directors of Marpai (“Founders Directors”) as well as against
any proposal to remove any of the Founders Directors (or such other nominees) as a director of Marpai.

 

7.             This
Power of Attorney and Proxy shall be binding upon the heirs, estate, executors, personal representatives, successors and assigns of the
undersigned (including any transferee of any of the shares, warrants or options held by the undersigned in Marpai); provided that this
Power and Attorney and Proxy is not binding on any purchaser of Proxy Shares who is not an Affiliate of any person or entity within the
Hillcour Founding Group or who is not an Affiliate of Damien Francis Lamendola.

 

    3 

     

    

 

8.              If any provision of this Power of Attorney and Proxy or any part of any such provision is held under any circumstances to be invalid
or unenforceable in any jurisdiction, then:

 

		(i)	such provision or part thereof shall be deemed amended to conform to applicable
laws so as to be valid and enforceable to the fullest possible extent,

		(ii)	the invalidity or unenforceability of such provision or part thereof shall not
affect the validity or enforceability of such provision or part thereof under any other circumstances or in any other jurisdiction, and

		(iii)	the invalidity or unenforceability of such provision or part thereof shall not
affect the validity or enforceability of the remainder of such provision or the validity or enforceability of any other provision of this
Power of Attorney and Proxy.

 

[Signature Page to Follow]

 

    3 

     

    

 

IN WITNESS WHEREOF, the
undersigned executed this Power of Attorney and Proxy this 28th day of June 2021.

 

 

	 HILLCOUR INVESTMENT FUND LLC 	   	   	   
	   	   	   	   	   
	 By: 	 /s/ Damien Lamendola 	   	   	   
	   	   	   	   	   
	   	 Name: 	 Damien Lamendola 	   	 Witness to signature: 	 /s/
                                            Dave Heuermann 

	   	   	   	   	   	   
	   	 Title: 	 Manager 	   	 Witness to signature: 	 /s/
                                            Wayne Watters 

 

	   	 STATE OF FLORIDA
     
	 COUNTRY OF HILLSBOROUGH 
	   
	 The Foregoing instrument was acknowledged before me this 28
day of June, 2021, by Damien Lamendola. 
	   
	   	 /s/ Tynecia L. Alsay 
	 (NOTARY SEAL) 	 (Signature of Notary Public-State
    of Florida) 
	   
	 (Name of Notary
    Typed, Printed, of Stamped)  
	   
	 Personally Known
      ̈ OR
    Produced Identification  x 
	   
	 Type of Identification
    Produced  
	 Drivers
    License 

 

	WELLENTERPRISES USA LLC	 	 	 
	 	 	 	 	 
	By:	/s/ Philip G. Mowry	 	 	 
	 	 	 	 	 
	 	Name:	Philip G. Mowry	 	Witness to signature:	/s/ Connie Raemaekers
	 	 	 	 	 	 
	 	Title:	Manager	 	Witness to signature:	/s/ Donna Penix

 

	   	 STATE OF FLORIDA  
	 COUNTRY OF POLK 
	   
	 The Foregoing instrument was acknowledged before me this 24th
day of June, 2021, by Philip G Mowry. 
	   
	   	 /s/ Martin B. Wilkey 
	 (NOTARY SEAL) 	 (Signature of Notary Public-State of Florida) 
	   
	 (Name of Notary Typed, Printed, of Stamped) 
	   
	 Personally Known  x  OR
    Produced Identification   ̈ 
	   
	 Type of Identification Produced  
	 FL DL M600-667-63-407-0

    ISS: 04/22/21

    ENP: 11/07/29 

 

	ELI DAVID	 	 	 
	 	 	 	 	 
	By:	/s/ Eli David	 	Witness to signature:	/s/ Simon Li

 

 

	YARON EITAN	 	 	 
	 	 	 	 	 
	By:	/s/ Yaron Eitan	 	Witness to signature:	/s/ Simon Li

 

	EDMUNDO GONZALEZ	 	 	 
	 	 	 	 	 
	By:	/s/ Edmundo Gonzalez	 	Witness to signature:	/s/ Simon Li

 

 

	GRAYS WEST VENTURES LLC
	 	 	 
	 	 	 	 	 
	By:	/s/ Edmundo Gonzalez	 	 	 
	 	Name:	Edmundo
Gonzalez	 	 	 
	 	Title:	Manager	 	Witness to signature:	/s/ Simon LI

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]